Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

Added 610 days ago (15.09.2020)
Authors: Faramand, R., Jain, M., Staedtke, V., Kotani, H., Bai, R., Reid, K., Lee, S. B., Spitler, K., Wang, X., Cao, B., Pinilla, J., Lazaryan, A., Khimani, F., Shah, B., Chavez, J. C., Nishihori, T., Mishra, A., Mullinax, J., Gonzalez, R., Hussaini, M., Dam, M., Brandjes, B. D., Bachmeier, C. A., Anasetti, C., Locke, F. L., Davila, M. L.
Read article